Tapewire

Nasdaq · USD

TNXP

Tonix Pharmaceuticals Holding Corp.

Export transactions ↓
Tapewire entity
6169
SEC CIK
0001430306
Parsed reports
210

Last 12 months

Inside the activity.

7 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202620
Apr 202600
May 202600
Jun 202630
Jul 202600
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 27, 2026 Filed Aug 31, 2026 12:00 UTC
LEDERMAN SETHDirector · Chief Executive Officer
PurchaseCommon Stock, $0.001 par value 2,000 $13.79 $27,580.00
Disclosure

SEC source: 0001493152-26-040736 · ownership.xml · nonDerivative · entry 1

LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA Account

Disclosed balance after: 11,005

F1 · ownership.nature: Reporting person may be deemed a control person of this entity.

Read SEC document
August 20, 2026 Filed Aug 24, 2026 12:00 UTC PurchaseCommon Stock, par value $0.001 1,000 $12.60 $12,600.00
Disclosure

SEC source: 0001999371-26-018494 · bagger-form4.xml · nonDerivative · entry 1

BAGGER RICHARD H · CIK 0001372907 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

Read SEC document
June 30, 2026 Filed Jul 9, 2026 13:05 UTC
SAENGER BRADLEYChief Financial Officer
OtherCommon Stock, $0.001 par value 1,453 $10.91 $15,858.04
Disclosure

SEC source: 0001493152-26-032615 · ownership.xml · nonDerivative · entry 1

SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,154

F1 · kind: Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2025 Employee Stock Purchase Plan.

Read SEC document
June 12, 2026 Filed Jun 15, 2026 11:00 UTC PurchaseCommon Stock, $0.001 par value 1,415 $10.55 $14,928.25
Disclosure

SEC source: 0001493152-26-028608 · ownership.xml · nonDerivative · entry 1

Taylor Carolyn E. · CIK 0001875324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,833

Read SEC document
June 09, 2026 Filed Jun 9, 2026 21:30 UTC
LEDERMAN SETHDirector · Chief Executive Officer
PurchaseCommon Stock, $0.001 par value 5,000 $11.79 $58,950.00
Disclosure

SEC source: 0001493152-26-027986 · ownership.xml · nonDerivative · entry 1

LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,005

F1 · price: Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $11.735 to $11.883 per share. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

Read SEC document
June 08, 2026 Filed Jun 9, 2026 21:30 UTC PurchaseCommon Stock, $0.001 par value 5,000 $11.65 $58,250.00
Disclosure

SEC source: 0001493152-26-027985 · ownership.xml · nonDerivative · entry 1

Stillwell Richard Newcomb · CIK 0001966861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

F1 · price: Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $11.63 to $11.65 per share. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

Read SEC document
May 12, 2026 Filed May 14, 2026 21:46 UTC GrantStock Option · Derivative 22,700 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001999371-26-010751 · hunter-form4_051426.xml · derivative · entry 1

Hunter James Randolph Jr · CIK 0002071788 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2036-05-12

F1 · price: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

Read SEC document
May 12, 2026 Filed May 14, 2026 21:48 UTC GrantStock Option · Derivative 22,700 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001999371-26-010754 · stillwell-form4_051426.xml · derivative · entry 1

Stillwell Richard Newcomb · CIK 0001966861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2036-05-12

F1 · price: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

Read SEC document
May 12, 2026 Filed May 14, 2026 21:41 UTC GrantStock Option · Derivative 22,700 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001999371-26-010747 · taylor-form4_051426.xml · derivative · entry 1

Taylor Carolyn E. · CIK 0001875324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2036-05-12

F1 · price: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

Read SEC document
May 12, 2026 Filed May 14, 2026 21:47 UTC GrantStock Option · Derivative 22,700 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001999371-26-010753 · olukotun-form4_051426.xml · derivative · entry 1

OLUKOTUN ADEOYE Y · CIK 0001242615 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2036-05-12

F1 · price: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

Read SEC document
May 12, 2026 Filed May 14, 2026 21:47 UTC GrantStock Option · Derivative 22,700 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001999371-26-010752 · bell-form4_051426.xml · derivative · entry 1

Bell Margaret Smith · CIK 0001716713 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2036-05-12

F1 · price: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

Read SEC document
May 12, 2026 Filed May 14, 2026 21:45 UTC
Treco JamesDirector
GrantStock Option · Derivative 22,700 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001999371-26-010750 · treco-form4_051426.xml · derivative · entry 1

Treco James · CIK 0001766070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2036-05-12

F1 · price: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

Read SEC document
May 12, 2026 Filed May 14, 2026 21:43 UTC GrantStock Option · Derivative 22,700 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001999371-26-010749 · grange-form4_051426.xml · derivative · entry 1

GRANGE DAVID L · CIK 0001264908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2036-05-12

F1 · price: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

Read SEC document
May 12, 2026 Filed May 14, 2026 21:42 UTC GrantStock Option · Derivative 22,700 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001999371-26-010748 · bagger-form4_051426.xml · derivative · entry 1

BAGGER RICHARD H · CIK 0001372907 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2036-05-12

F1 · price: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 13:31 UTC
LEDERMAN SETHDirector · Chief Executive Officer
PurchaseCommon Stock, $0.001 par value 5,000 $12.62 $63,100.00
Disclosure

SEC source: 0001999371-26-007447 · ownership.xml · nonDerivative · entry 1

LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA Account

Disclosed balance after: 20,001

F1 · price: Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $12.5699 to $12.625 per share. The Reporting Persons undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

F2 · ownership.nature: Reporting person may be deemed a control person of this entity.

Read SEC document
March 18, 2026 Filed Mar 18, 2026 21:03 UTC
LEDERMAN SETHDirector · Chief Executive Officer
PurchaseCommon Stock, $0.001 par value 15,000 $14.89 $223,350.00
Disclosure

SEC source: 0001999371-26-006235 · form4-lederman_031826.xml · nonDerivative · entry 1

LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA Account

Disclosed balance after: 15,001

F1 · ownership.nature: Reporting person may be deemed a control person of this entity.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 07:02 UTC
Fogarty SiobhanChief Technology Officer
GrantStock Option · Derivative 39,011 $0.00 Strike: $17.86 $0.00
Disclosure

SEC source: 0001999371-26-004386 · fogarty-form4_022626.xml · derivative · entry 2

Fogarty Siobhan · CIK 0002055825 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,011

Underlying: Common Stock · 39,011 shares

Expires 2036-02-24

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.

F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 07:02 UTC
Fogarty SiobhanChief Technology Officer
GrantStock Option · Derivative 39,012 $0.00 Strike: $14.29 $0.00
Disclosure

SEC source: 0001999371-26-004386 · fogarty-form4_022626.xml · derivative · entry 1

Fogarty Siobhan · CIK 0002055825 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,012

Underlying: Common Stock · 39,012 shares

Expires 2036-02-24

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.

F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 12:03 UTC
SAENGER BRADLEYChief Financial Officer
GrantStock Option · Derivative 39,011 $0.00 Strike: $17.86 $0.00
Disclosure

SEC source: 0001999371-26-004388 · saenger-form4_022626.xml · derivative · entry 2

SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,011

Underlying: Common Stock · 39,011 shares

Expires 2036-02-24

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.

F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 12:03 UTC
SAENGER BRADLEYChief Financial Officer
GrantStock Option · Derivative 39,012 $0.00 Strike: $14.29 $0.00
Disclosure

SEC source: 0001999371-26-004388 · saenger-form4_022626.xml · derivative · entry 1

SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,012

Underlying: Common Stock · 39,012 shares

Expires 2036-02-24

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.

F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 07:02 UTC
SULLIVAN GREGORY MChief Medical Officer
GrantStock Option · Derivative 39,011 $0.00 Strike: $17.86 $0.00
Disclosure

SEC source: 0001999371-26-004387 · sullivan-form4_022626.xml · derivative · entry 2

SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,011

Underlying: Common Stock · 39,011 shares

Expires 2036-02-24

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.

F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 07:02 UTC
SULLIVAN GREGORY MChief Medical Officer
GrantStock Option · Derivative 39,012 $0.00 Strike: $14.29 $0.00
Disclosure

SEC source: 0001999371-26-004387 · sullivan-form4_022626.xml · derivative · entry 1

SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,012

Underlying: Common Stock · 39,012 shares

Expires 2036-02-24

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.

F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 12:03 UTC
MORRIS JESSICA EDGARChief Operating Officer
GrantStock Option · Derivative 39,011 $0.00 Strike: $17.86 $0.00
Disclosure

SEC source: 0001999371-26-004389 · morris-form4_022626.xml · derivative · entry 2

MORRIS JESSICA EDGAR · CIK 0001656531 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,011

Underlying: Common Stock · 39,011 shares

Expires 2036-02-24

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.

F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 12:03 UTC
MORRIS JESSICA EDGARChief Operating Officer
GrantStock Option · Derivative 39,012 $0.00 Strike: $14.29 $0.00
Disclosure

SEC source: 0001999371-26-004389 · morris-form4_022626.xml · derivative · entry 1

MORRIS JESSICA EDGAR · CIK 0001656531 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,012

Underlying: Common Stock · 39,012 shares

Expires 2036-02-24

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.

F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 12:01 UTC
LEDERMAN SETHDirector · Chief Executive Officer
GrantStock Option · Derivative 134,503 $0.00 Strike: $17.86 $0.00
Disclosure

SEC source: 0001999371-26-004385 · lederman-form4_022626.xml · derivative · entry 2

LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,503

Underlying: Common Stock · 134,503 shares

Expires 2036-02-24

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.

F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 12:01 UTC
LEDERMAN SETHDirector · Chief Executive Officer
GrantStock Option · Derivative 134,504 $0.00 Strike: $14.29 $0.00
Disclosure

SEC source: 0001999371-26-004385 · lederman-form4_022626.xml · derivative · entry 1

LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,504

Underlying: Common Stock · 134,504 shares

Expires 2036-02-24

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.

F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months.

Read SEC document
December 31, 2025 Filed Feb 17, 2026 12:00 UTC
SAENGER BRADLEYChief Financial Officer · 10% owner
GrantCommon Stock, par value $0.001 701 $13.42 $9,407.42
Disclosure

SEC source: 0001999371-26-003371 · saenger-form5_021626.xml · nonDerivative · entry 1

SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 701

F1 · kind: Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2025 Employee Stock Purchase Plan.

Read SEC document
August 21, 2025 Filed Aug 21, 2025 21:22 UTC PurchaseCommon Stock, par value $0.001 418 $36.03 $15,060.54
Disclosure

SEC source: 0001999371-25-011836 · taylor-form4_082125.xml · nonDerivative · entry 1

Taylor Carolyn E. · CIK 0001875324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 418

F1 · price: Represents the weighted average purchase price. Actual purchase prices ranged from $35.98 to $36.05.

Read SEC document
August 20, 2025 Filed Aug 20, 2025 20:15 UTC
Treco JamesDirector
PurchaseCommon Stock, par value $0.001 250 $36.00 $9,000.00
Disclosure

SEC source: 0001999371-25-011754 · treco-form4_082025.xml · nonDerivative · entry 1

Treco James · CIK 0001766070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250

Read SEC document
June 12, 2025 Filed Jun 13, 2025 20:42 UTC GrantStock Option · Derivative 7,740 $0.00 Strike: $34.54 $0.00
Disclosure

SEC source: 0001999371-25-007769 · hunter-form4.xml · derivative · entry 1

Hunter James Randolph Jr · CIK 0002071788 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,740

Underlying: Common Stock · 7,740 shares

Expires 2035-06-12

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.

F1 · derivative.exercise_date: The option vests on the date of the Company's 2026 annual meeting of stockholders.

Read SEC document
May 15, 2025 Filed May 15, 2025 21:08 UTC
LEDERMAN SETHDirector · Chief Executive Officer
PurchaseCommon Stock, $0.001 par value 4,000 $21.55 $86,200.00
Disclosure

SEC source: 0001999371-25-006261 · lederman-ownership.xml · nonDerivative · entry 1

LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,005

Read SEC document
May 13, 2025 Filed May 15, 2025 20:51 UTC GrantStock Option · Derivative 10,000 $0.00 Strike: $20.18 $0.00
Disclosure

SEC source: 0001999371-25-006245 · stillwell-form4.xml · derivative · entry 1

Stillwell Richard Newcomb · CIK 0001966861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2035-05-13

F1 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

Read SEC document
May 13, 2025 Filed May 15, 2025 20:57 UTC GrantStock Option · Derivative 10,000 $0.00 Strike: $20.18 $0.00
Disclosure

SEC source: 0001999371-25-006250 · taylor-form4.xml · derivative · entry 1

Taylor Carolyn E. · CIK 0001875324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2035-05-13

F1 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

Read SEC document
May 13, 2025 Filed May 15, 2025 21:04 UTC
Treco JamesDirector
GrantStock Option · Derivative 10,000 $0.00 Strike: $20.18 $0.00
Disclosure

SEC source: 0001999371-25-006255 · treco-form4.xml · derivative · entry 1

Treco James · CIK 0001766070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2035-05-13

F1 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

Read SEC document
May 13, 2025 Filed May 15, 2025 21:00 UTC GrantStock Option · Derivative 10,000 $0.00 Strike: $20.18 $0.00
Disclosure

SEC source: 0001999371-25-006253 · bell-form4.xml · derivative · entry 1

Bell Margaret Smith · CIK 0001716713 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2035-05-13

F1 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

Read SEC document
May 13, 2025 Filed May 15, 2025 20:54 UTC GrantStock Option · Derivative 10,000 $0.00 Strike: $20.18 $0.00
Disclosure

SEC source: 0001999371-25-006248 · bagger-form4.xml · derivative · entry 1

BAGGER RICHARD H · CIK 0001372907 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2035-05-13

F1 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

Read SEC document
May 13, 2025 Filed May 15, 2025 20:49 UTC GrantStock Option · Derivative 10,000 $0.00 Strike: $20.18 $0.00
Disclosure

SEC source: 0001999371-25-006242 · olukotun-form4.xml · derivative · entry 1

OLUKOTUN ADEOYE Y · CIK 0001242615 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2035-05-13

F1 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

Read SEC document
May 13, 2025 Filed May 15, 2025 20:47 UTC GrantStock Option · Derivative 10,000 $0.00 Strike: $20.18 $0.00
Disclosure

SEC source: 0001999371-25-006236 · grange-form4.xml · derivative · entry 1

GRANGE DAVID L · CIK 0001264908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2035-05-13

F1 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 18:42 UTC
Fogarty SiobhanChief Technology Officer
GrantStock Option · Derivative 13,500 $0.00 Strike: $10.06 $0.00
Disclosure

SEC source: 0001839882-25-011945 · fogarty-form4_022725.xml · derivative · entry 2

Fogarty Siobhan · CIK 0002055825 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 13,500 shares

Expires 2035-02-25

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 18:42 UTC
Fogarty SiobhanChief Technology Officer
GrantStock Option · Derivative 13,500 $0.00 Strike: $8.05 $0.00
Disclosure

SEC source: 0001839882-25-011945 · fogarty-form4_022725.xml · derivative · entry 1

Fogarty Siobhan · CIK 0002055825 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 13,500 shares

Expires 2035-02-25

F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 23:51 UTC
SAENGER BRADLEYChief Financial Officer
GrantStock Option · Derivative 25,792 $0.00 Strike: $10.06 $0.00
Disclosure

SEC source: 0001839882-25-011958 · saenger-form4_022725.xml · derivative · entry 3

SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,792

Underlying: Common Stock · 25,792 shares

Expires 2035-02-25

F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

F2 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 23:51 UTC
SAENGER BRADLEYChief Financial Officer
GrantStock Option · Derivative 25,792 $0.00 Strike: $8.05 $0.00
Disclosure

SEC source: 0001839882-25-011958 · saenger-form4_022725.xml · derivative · entry 2

SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,792

Underlying: Common Stock · 25,792 shares

Expires 2035-02-25

F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

F2 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 18:49 UTC
SULLIVAN GREGORY MChief Medical Officer
GrantStock Option · Derivative 29,017 $0.00 Strike: $10.06 $0.00
Disclosure

SEC source: 0001839882-25-011955 · sullivan_form4-022725.xml · derivative · entry 3

SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,017

Underlying: Common Stock · 29,017 shares

Expires 2035-02-25

F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

F2 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 18:49 UTC
SULLIVAN GREGORY MChief Medical Officer
GrantStock Option · Derivative 29,017 $0.00 Strike: $8.05 $0.00
Disclosure

SEC source: 0001839882-25-011955 · sullivan_form4-022725.xml · derivative · entry 2

SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,017

Underlying: Common Stock · 29,017 shares

Expires 2035-02-25

F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

F2 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 23:44 UTC
MORRIS JESSICA EDGARChief Operating Officer
GrantStock Option · Derivative 29,291 $0.00 Strike: $10.06 $0.00
Disclosure

SEC source: 0001839882-25-011949 · morris_form4-022725.xml · derivative · entry 3

MORRIS JESSICA EDGAR · CIK 0001656531 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,291

Underlying: Common Stock · 29,291 shares

Expires 2035-02-25

F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

F2 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 23:44 UTC
MORRIS JESSICA EDGARChief Operating Officer
GrantStock Option · Derivative 29,291 $0.00 Strike: $8.05 $0.00
Disclosure

SEC source: 0001839882-25-011949 · morris_form4-022725.xml · derivative · entry 2

MORRIS JESSICA EDGAR · CIK 0001656531 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,291

Underlying: Common Stock · 29,291 shares

Expires 2035-02-25

F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

F2 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 23:48 UTC
LEDERMAN SETHDirector · Chief Executive Officer
GrantStock Option · Derivative 123,958 $0.00 Strike: $10.06 $0.00
Disclosure

SEC source: 0001839882-25-011952 · lederman-form4_022725.xml · derivative · entry 8

LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,958

Underlying: Common Stock · 123,958 shares

Expires 2035-02-25

F4 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

F3 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 23:48 UTC
LEDERMAN SETHDirector · Chief Executive Officer
GrantStock Option · Derivative 123,958 $0.00 Strike: $8.05 $0.00
Disclosure

SEC source: 0001839882-25-011952 · lederman-form4_022725.xml · derivative · entry 7

LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,958

Underlying: Common Stock · 123,958 shares

Expires 2035-02-25

F4 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

F3 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.

Read SEC document
February 05, 2025 Filed Feb 27, 2025 23:51 UTC
SAENGER BRADLEYChief Financial Officer
OtherCommon Stock, par value $0.001 0.04 $0.00 $0.00
Disclosure

SEC source: 0001839882-25-011958 · saenger-form4_022725.xml · nonDerivative · entry 1

SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Shares were surrendered without considerations following a reverse stock split of the Issuer's common stock.

Read SEC document
February 05, 2025 Filed Feb 27, 2025 18:49 UTC
SULLIVAN GREGORY MChief Medical Officer
OtherCommon Stock, par value $0.001 0.11 $1.47 $0.16
Disclosure

SEC source: 0001839882-25-011955 · sullivan_form4-022725.xml · nonDerivative · entry 1

SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.